CONVERTIBLE PROMISSORY NOTES AND SHORT TERM LOANS (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Mar. 31, 2022 |
Dec. 21, 2021 |
Jan. 08, 2021 |
|
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
Debt Instrument, Face Amount | $ 12,000,000 | |||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 1.06 | |||||
Debt Issuance Costs, Net | $ 193,437 | |||||
Class of Warrant or Right, Outstanding | 97,500 | 658,355 | ||||
Conversion Notice [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
Debt Conversion, Description | The holder may exercise such conversion right by providing written notice to the Company of such exercise in a form reasonably acceptable to the Company (a “conversion notice”). Conversion price means (subject in all cases to proportionate adjustment for stock splits, stock dividends, and similar transactions), seventy-five percent (75%) multiplied by the average of the three (3) lowest closing prices during the previous ten (10) trading days prior to the receipt of the conversion notice | |||||
Noteholders [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
Convertible Notes Payable | $ 1,238,000 | |||||
Warrant [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
[custom:PlacementAgentFeesDescription] | The Company was obligated to issue warrants that accompany the convertible notes and provide 50% warrant coverage. The warrants have a 3-year term from date of issuance and an exercise price that is 120% of the 20-day volume weighted average price of the Company’s common shares at the time final closing | |||||
Warrant [Member] | Placement Agent [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
[custom:PlacementAgentFeesDescription] | The Company was also obligated to issue warrants to the placement agent that have a 10-year term and cover 12% of funds raised for $8,925,550 (face value) of the notes (first series) and 2.5% of funds raised for the remaining $2,350,000 (face value) of notes (second series), with an exercise price that is 120% of the 20-day volume weighted average price of the Company’s common shares at the time final closing. On final closing, which occurred on January 8, 2021, the warrants’ exercise price was struck at $1.06 per share | |||||
Series A Notes [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
Debt Instrument, Face Amount | $ 11,275,500 | $ 700,000 | ||||
Debt Instrument, Interest Rate, Stated Percentage | 12.00% | |||||
Debt Conversion, Description | the notes would automatically convert into common stock (in each case, subject to the trading volume of the Company’s common stock being a minimum of $500,000 for each trading day in the 20 consecutive trading days immediately preceding the conversion date), upon the earlier to occur of (i) the Company’s common stock being listed on a national securities exchange, in which event the conversion price would be equal to 75% of the volume weighted average price of the common stock for the 20 trading days prior to the conversion date, or (ii) upon the closing of the Company’s next equity round of financing for gross proceeds of greater than $5,000,000, in which event the conversion price would be equal to 75% of the price per share of the common stock (or of the conversion price in the event of the sale of securities convertible into common stock) sold in such financing. The Company could, at its discretion redeem the notes for 115% of their face value plus accrued interest | |||||
Proceeds from Convertible Debt | 10,135,690 | |||||
Debt Issuance Costs, Net | $ 2,301,854 | |||||
Debt Instrument, Unamortized Discount | 8,088,003 | |||||
Interest Payable | $ 129,699 | |||||
Series A Notes [Member] | Placement Agent [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
[custom:PlacementAgentFeesDescription] | The Company was obligated to pay the placement agent of the first series of Series A Notes a 12% cash fee for $8,925,550 (face value) of the notes and 2.5% cash fee and other sundry expenses for the remaining $2,350,000 (face value) of the notes | |||||
Series A Notes Second [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
Debt Conversion, Description | the notes would automatically convert into common stock (in each case, subject to the trading volume of the Company’s common stock being a minimum of $500,000 for each trading day in the 20 consecutive trading days immediately preceding the conversion date), upon the earlier to occur of (i) the Company’s common stock being listed on a national securities exchange, in which event the conversion price would be equal to the lower of $4.00 per share or 75% of the volume weighted average price of the common stock for the 20 trading days prior to the conversion date, or (ii) upon the closing of the Company’s next equity round of financing for gross proceeds of greater than $5,000,000, in which event the conversion price would be equal to the lower of $4.00 per share or 75% of the price per share of the common stock (or of the conversion price in the event of the sale of securities convertible into common stock) sold in such financing. The Company could, at its discretion redeem the notes for 115% of their face value plus accrued interest | |||||
Sale of Stock, Price Per Share | $ 4.00 | |||||
Series B Notes [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
Debt Instrument, Face Amount | 840,000 | |||||
Debt Conversion, Description | The Series B Notes will automatically convert into common stock upon a merger, consolidation, exchange of shares, recapitalization, reorganization, as a result of which the Company’s common stock shall be changed into another class or classes of stock of the Company or another entity, or in the case of the sale of all or substantially all of the assets of the Company other than a complete liquidation of the Company. Within the first 180 days after the issuance date, the Company may, at its discretion redeem the notes for 115% of their face value plus accrued interest. The Company is obligated to issue warrants that accompany the convertible notes and provide 50% warrant coverage | |||||
Proceeds from Convertible Debt | 1,240,000 | |||||
Debt Issuance Costs, Net | 10,000 | |||||
Debt Instrument, Unamortized Discount | $ 1,312,500 | |||||
Interest Payable | $ 74,550 | |||||
Debt Conversion, Converted Instrument, Amount | $ 302,000 | |||||
Debt Conversion, Converted Instrument, Shares Issued | 390,464 | |||||
Series B Notes [Member] | Accreditor Investors [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
Debt Instrument, Face Amount | $ 1,312,500 | |||||
Series B Notes [Member] | Warrant [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 1.06 | $ 100,000 | ||||
Warrants and Rights Outstanding, Term | 3 years | |||||
Class of Warrant or Right, Outstanding | 212,500 | |||||
Series B Notes [Member] | Warrant One [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 1.5 | |||||
General and Administrative Expense [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
Interest Expense | $ 0 | $ 56,220 | ||||
General and Administrative Expenses [Member] | ||||||
Obligation with Joint and Several Liability Arrangement [Line Items] | ||||||
Interest Expense, Debt | $ 31,414 | $ 265,658 |